{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:03:37Z","timestamp":1790633017016,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12883-019-1359-6","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T08:05:59Z","timestamp":1560413159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2635-6537","authenticated-orcid":false,"given":"Neringa","family":"Jucevi\u010di\u016bt\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulius","family":"Miku\u017eis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Balnyt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"1359_CR1","volume-title":"Deaths by cause, age, sex, by country and by region, 2000-2016","author":"Global Health Estimates","year":"2016","unstructured":"Global Health Estimates. Deaths by cause, age, sex, by country and by region, 2000-2016. Geneva: World Heal Organ 2018; 2016. \n                    http:\/\/www.who.int\/healthinfo\/global_burden_disease\/estimates\/en\/index1.html\n                    \n                   (Accessed 28 July 2018"},{"key":"1359_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clineuro.2017.05.019","volume":"159","author":"R Alexandru","year":"2017","unstructured":"Alexandru R, Terecoas\u0103 EO, B\u0103jenaru OA, Tiu C. Etiologic classification of ischemic stroke: where do we stand? Clin Neurol Neurosurg. 2017;159:93\u2013106. \n                    https:\/\/doi.org\/10.1016\/j.clineuro.2017.05.019\n                    \n                  .","journal-title":"Clin Neurol Neurosurg"},{"key":"1359_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5853\/jos.2016.01515","volume":"19","author":"PI dela","year":"2017","unstructured":"dela PI, Borlongan C, Shen G, Davis W. Strategies to extend thrombolytic time window for ischemic stroke treatment: an unmet clinical need. J Stroke. 2017;19:50\u201360. \n                    https:\/\/doi.org\/10.5853\/jos.2016.01515\n                    \n                  .","journal-title":"J Stroke"},{"key":"1359_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1941875211408731","volume":"1","author":"DJ Miller","year":"2011","unstructured":"Miller DJ, Simpson JR, Silver B. Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies. The Neurohospitalist. 2011;1:138\u201347. \n                    https:\/\/doi.org\/10.1177\/1941875211408731\n                    \n                  .","journal-title":"The Neurohospitalist"},{"key":"1359_CR5","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","volume":"375","author":"KR Lees","year":"2010","unstructured":"Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695\u2013703. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(10)60491-6\n                    \n                  .","journal-title":"Lancet"},{"key":"1359_CR6","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","volume":"43","author":"WN Whiteley","year":"2012","unstructured":"Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke. 2012;43:2904\u20139. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.112.665331\n                    \n                  .","journal-title":"Stroke"},{"key":"1359_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/WCO.0b013e328352ede6","volume":"25","author":"T Magnus","year":"2012","unstructured":"Magnus T, Wiendl H, Kleinschnitz C. Immune mechanisms of stroke. Curr Opin Neurol. 2012;25:334\u201340. \n                    https:\/\/doi.org\/10.1097\/WCO.0b013e328352ede6\n                    \n                  .","journal-title":"Curr Opin Neurol"},{"key":"1359_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1001\/archneurol.2011.3590.Brain-Immune","volume":"69","author":"H Kamel","year":"2012","unstructured":"Kamel H, Iadecola C, Implications C, Kamel H, Iadecola C, Implications C, et al. Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol. 2012;69:576\u201381. \n                    https:\/\/doi.org\/10.1001\/archneurol.2011.3590.Brain-Immune\n                    \n                  .","journal-title":"Arch Neurol"},{"key":"1359_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrneurol.2015.144","volume":"11","author":"Y Fu","year":"2015","unstructured":"Fu Y, Liu Q, Anrather J, Shi F. Immune interventions in stroke. Nat Rev Neurol. 2015;11:524\u201335. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2015.144\n                    \n                  .","journal-title":"Nat Rev Neurol"},{"key":"1359_CR10","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.7860\/JCDR\/2013\/6004.3512","volume":"7","author":"GA Khwaja","year":"2013","unstructured":"Khwaja GA, Duggal A, Kulkarni A, Choudhary N, Gupta M, Chowdhury D, et al. Hypereosinophilia-an unusual cause of multiple embolic strokes and multi-organ dysfunction. J Clin Diagnostic Res. 2013;7:2316\u20138. \n                    https:\/\/doi.org\/10.7860\/JCDR\/2013\/6004.3512\n                    \n                  .","journal-title":"J Clin Diagnostic Res"},{"key":"1359_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archneurol.2010.256","volume":"67","author":"H Sethi","year":"2010","unstructured":"Sethi H, Schmidley J. Cerebral infarcts in the setting of eosinophilia three cases and a discussion. Arch Neurol. 2010;67:1275\u20137. \n                    https:\/\/doi.org\/10.1001\/archneurol.2010.256\n                    \n                  .","journal-title":"Arch Neurol"},{"key":"1359_CR12","unstructured":"WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Who2 2006. doi: ISBN 92 4 159493 4."},{"key":"1359_CR13","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1159\/000131083","volume":"25","author":"PA Ringleb","year":"2008","unstructured":"Ringleb PA, Bousser M, Ford G, Bath P, Brainin M, Caso V, et al. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008 The European Stroke Organization ( ESO ) Committee and the ESO Writing Committee Executive. Stroke. 2008;25:6855\u20139. \n                    https:\/\/doi.org\/10.1159\/000131083\n                    \n                  .","journal-title":"Stroke"},{"key":"1359_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C, Von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245\u201351. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(98)08020-9\n                    \n                  .","journal-title":"Lancet"},{"key":"1359_CR15","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.12.007","volume":"25","author":"YS Hori","year":"2016","unstructured":"Hori YS, Kodera S, Sato Y, Shiojiri T. Eosinopenia as a predictive factor of the short-term risk of mortality and infection after acute cerebral infarction. J Stroke Cerebrovasc Dis. 2016;25:1307\u201312. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.12.007\n                    \n                  .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1359_CR16","first-page":"3643","volume":"19","author":"L Guo","year":"2015","unstructured":"Guo L, Liu S, Zhang F, Mao G, Sun L, Liu Y. The role of eosinophils in stroke: a pilot study. Eur Rev Med Pharmacol Sci. 2015;19:3643\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1359_CR17","doi-asserted-by":"publisher","first-page":"104238","DOI":"10.18632\/oncotarget.22199","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Ma L, Lin T, Li SJ, Chen LL, Wang DZ. The significance of eosinophils in predicting the severity of acute ischemic stroke. Oncotarget. 2017;8:104238\u201346. \n                    https:\/\/doi.org\/10.18632\/oncotarget.22199\n                    \n                  .","journal-title":"Oncotarget"},{"key":"1359_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0680-x","volume":"13","author":"Z Guo","year":"2016","unstructured":"Guo Z, Yu S, Xiao L, Chen X, Ye R, Zheng P, et al. Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke. J Neuroinflammation. 2016;13:199. \n                    https:\/\/doi.org\/10.1186\/s12974-016-0680-x\n                    \n                  .","journal-title":"J Neuroinflammation"},{"key":"1359_CR19","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.12659\/MSM.907919","volume":"23","author":"H Ren","year":"2017","unstructured":"Ren H, Han L, Liu H, Wang L, Liu X, Gao Y. Decreased lymphocyte-to-monocyte ratio predicts poor prognosis of acute ischemic stroke treated with thrombolysis. Med Sci Monit. 2017;23:5826\u201333. \n                    https:\/\/doi.org\/10.12659\/MSM.907919\n                    \n                  .","journal-title":"Med Sci Monit"},{"key":"1359_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000345087","volume":"35","author":"J-G Lee","year":"2013","unstructured":"Lee J-G, Lee KB, Jang I-M, Roh H, Ahn M-Y, Woo H-Y, et al. Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke. Cerebrovasc Dis. 2013;35:53\u20139. \n                    https:\/\/doi.org\/10.1159\/000345087\n                    \n                  .","journal-title":"Cerebrovasc Dis"},{"key":"1359_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/archneurol.2010.25","volume":"67","author":"S Prabhakaran","year":"2010","unstructured":"Prabhakaran S, Rivolta J, Vieira JR, Rincon F, Stillman J, Marshall RS, et al. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2010;67:559\u201363.","journal-title":"Arch Neurol"},{"key":"1359_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399.The","volume":"17","author":"C Iadecola","year":"2012","unstructured":"Iadecola C, Anrathner J. The immunology of stroke: from mechanism to translation. Nat Med. 2012;17:796\u2013808. \n                    https:\/\/doi.org\/10.1038\/nm.2399.The\n                    \n                  .","journal-title":"Nat Med"},{"key":"1359_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0171558","volume":"12","author":"Z Merali","year":"2017","unstructured":"Merali Z, Huang K, Mikulis D, Silver F, Kassner A. Evolution of blood-brain-barrier permeability after acute ischemic stroke. PLoS One. 2017;12:1\u201311. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0171558\n                    \n                  .","journal-title":"PLoS One"},{"key":"1359_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s13311-016-0458-y","volume":"13","author":"R Veltkamp","year":"2016","unstructured":"Veltkamp R, Gill D. Clinical trials of immunomodulation in ischemic stroke. Neurotherapeutics. 2016;13:791\u2013800. \n                    https:\/\/doi.org\/10.1007\/s13311-016-0458-y\n                    \n                  .","journal-title":"Neurotherapeutics"},{"key":"1359_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00570","volume":"5","author":"F Davoine","year":"2014","unstructured":"Davoine F, Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol. 2014;5:1\u201317. \n                    https:\/\/doi.org\/10.3389\/fimmu.2014.00570\n                    \n                  .","journal-title":"Front Immunol"},{"key":"1359_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1189\/jlb.72.4.769","volume":"72","author":"G Woerly","year":"2002","unstructured":"Woerly G, Lacy P, Ben Younes A, Roger N, Loiseau S, Moqbel R, et al. Human eosinophils express and release IL-13 following CD28-dependent activation. J Leukoc Biol. 2002;72:769\u201379. \n                    https:\/\/doi.org\/10.1189\/jlb.72.4.769\n                    \n                  .","journal-title":"J Leukoc Biol"},{"key":"1359_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajpath.2011.04.025","volume":"179","author":"D Piehler","year":"2011","unstructured":"Piehler D, Stenzel W, Grahnert A, Held J, Richter L, K\u00f6hler G, et al. Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am J Pathol. 2011;179:733\u201344. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2011.04.025\n                    \n                  .","journal-title":"Am J Pathol"},{"key":"1359_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol. 2016;173:649\u201365. \n                    https:\/\/doi.org\/10.1111\/bph.13139\n                    \n                  .","journal-title":"Br J Pharmacol"},{"key":"1359_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/187152710791012053","volume":"9","author":"CA Colton","year":"2010","unstructured":"Colton CA, Wilcock DM. Assessing activation states in microglia. CNS Neurol Disord - Drug Targets. 2010;9:174\u201391. \n                    https:\/\/doi.org\/10.2174\/187152710791012053\n                    \n                  .","journal-title":"CNS Neurol Disord - Drug Targets"},{"key":"1359_CR30","first-page":"73","volume":"5","author":"AR Patel","year":"2013","unstructured":"Patel AR, Ritzel R, McCullough LD, Liu F. Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol. 2013;5:73\u201390.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"1359_CR31","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1161\/STROKEAHA.112.659656","volume":"43","author":"X Hu","year":"2012","unstructured":"Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, et al. Microglia\/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43:3063\u201370. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.112.659656\n                    \n                  .","journal-title":"Stroke"},{"key":"1359_CR32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.biocel.2004.09.001","volume":"37","author":"I Puxeddu","year":"2005","unstructured":"Puxeddu I, Alian A, Piliponsky AM, Ribatti D, Panet A, Levi-Schaffer F. Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol. 2005;37:628\u201336. \n                    https:\/\/doi.org\/10.1016\/j.biocel.2004.09.001\n                    \n                  .","journal-title":"Int J Biochem Cell Biol"},{"key":"1359_CR33","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s00018-013-1282-8.Vascular","volume":"70","author":"D Greenberg","year":"2013","unstructured":"Greenberg D, Jin K. Vascular endeothelial growth factros (VEGFs) and stroke. Cell Mol Life Sci Mol Life Sci. 2013;70:1753\u201361. \n                    https:\/\/doi.org\/10.1007\/s00018-013-1282-8.Vascular\n                    \n                  .","journal-title":"Cell Mol Life Sci Mol Life Sci"},{"key":"1359_CR34","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/sj.jcbfm.9600109","volume":"25","author":"D Kaya","year":"2005","unstructured":"Kaya D, G\u00fcrsoy-\u00d6zdemir Y, Yemisci M, Tuncer N, Aktan S, Dalkara T. VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab. 2005;25:1111\u20138. \n                    https:\/\/doi.org\/10.1038\/sj.jcbfm.9600109\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"key":"1359_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-014-1381-0","volume":"129","author":"I Perez-de-Puig","year":"2015","unstructured":"Perez-de-Puig I, Mir\u00f3-Mur F, Ferrer-Ferrer M, Gelpi E, Pedragosa J, Justicia C, et al. Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol. 2015;129:239\u201357. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1381-0\n                    \n                  .","journal-title":"Acta Neuropathol"},{"key":"1359_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000053598","volume":"120","author":"T Fujisawa","year":"1999","unstructured":"Fujisawa T, Kato Y, Terada A, Iguchi K, Kamiya H. Matrix Metalloproteinase-9 in peripheral blood eosinophils. Int Arch Allergy Immunol. 1999;120:65\u20139. \n                    https:\/\/doi.org\/10.1159\/000053598\n                    \n                  .","journal-title":"Int Arch Allergy Immunol"},{"key":"1359_CR37","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/j.1365-2222.2012.04060.x","volume":"42","author":"S Esnault","year":"2012","unstructured":"Esnault S, Kelly EAB, Nettenstrom LM, Cook EB, Seroogy CM, Jarjour NN. Human eosinophils release IL-1\u00df and increase expression of IL-17A in activated CD4 + T lymphocytes. Clin Exp Allergy. 2012;42:1756\u201364. \n                    https:\/\/doi.org\/10.1111\/j.1365-2222.2012.04060.x\n                    \n                  .","journal-title":"Clin Exp Allergy"},{"key":"1359_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ni.1981","volume":"12","author":"VT Chu","year":"2011","unstructured":"Chu VT, Fr\u00f6hlich A, Steinhauser G, Scheel T, Roch T, Fillatreau S, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011;12:151\u20139. \n                    https:\/\/doi.org\/10.1038\/ni.1981\n                    \n                  .","journal-title":"Nat Immunol"},{"key":"1359_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1\u201312. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2016.03.010\n                    \n                  .","journal-title":"Brain Behav Immun"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1359-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T23:19:47Z","timestamp":1591917587000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1359-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1359-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Lithuanian University of Health Sciences Bioethics Committee. The patients had previously given written informed consent for use of their data from medical records in clinical research conducted in the Hospital of Lithuanian University of Health Sciences with the right to withdraw their consent at any time, thus, written consent from the patients or their relatives for participation in this study specifically was not obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}